Nanjing Leads Biolabs (9887) Announces Extraordinary General Meeting on December 17, 2025

Bulletin Express11-28

Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has released a proxy form for an Extraordinary General Meeting (EGM) scheduled for December 17, 2025, at 10:00 a.m. The EGM will take place on Floor 8, Building 03, 18E, Jialingjiang Street, Nanjing, the People’s Republic of China. Shareholders can vote in person or appoint proxies to vote on their behalf.

The agenda includes proposals to adopt and authorize an H Share Award Scheme, subject to relevant approvals and certain share issuance limits not exceeding 5% of the total shares in issue as of the date of passing the resolution. Other major items cover a Service Provider Sublimit under the H Share Award Scheme and a proposed cancellation of the Supervisory Committee, alongside amendments to the Company’s Articles of Association.

Shareholders must submit completed proxy forms, together with any required authorization documents, no later than 24 hours before the scheduled start of the EGM. Attendance in person requires appropriate proof of identity. Further details and specific instructions, including procedures for voting, are outlined in the official proxy form and notice of the EGM.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137190048?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 22:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137190048","market":"hk","top_or_hot":-1,"title":"Nanjing Leads Biolabs (9887) Announces Extraordinary General Meeting on December 17, 2025","media":"Bulletin Express","content":"<p>Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has released a proxy form for an Extraordinary General Meeting (EGM) scheduled for December 17, 2025, at 10:00 a.m. The EGM will take place on Floor 8, Building 03, 18E, Jialingjiang Street, Nanjing, the People’s Republic of China. Shareholders can vote in person or appoint proxies to vote on their behalf.</p>\n<p>The agenda includes proposals to adopt and authorize an H Share Award Scheme, subject to relevant approvals and certain share issuance limits not exceeding 5% of the total shares in issue as of the date of passing the resolution. Other major items cover a Service Provider Sublimit under the H Share Award Scheme and a proposed cancellation of the Supervisory Committee, alongside amendments to the Company’s Articles of Association.</p>\n<p>Shareholders must submit completed proxy forms, together with any required authorization documents, no later than 24 hours before the scheduled start of the EGM. Attendance in person requires appropriate proof of identity. Further details and specific instructions, including procedures for voting, are outlined in the official proxy form and notice of the EGM.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nanjing Leads Biolabs (9887) Announces Extraordinary General Meeting on December 17, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNanjing Leads Biolabs (9887) Announces Extraordinary General Meeting on December 17, 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-28 22:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has released a proxy form for an Extraordinary General Meeting (EGM) scheduled for December 17, 2025, at 10:00 a.m. The EGM will take place on Floor 8, Building 03, 18E, Jialingjiang Street, Nanjing, the People’s Republic of China. Shareholders can vote in person or appoint proxies to vote on their behalf.</p>\n<p>The agenda includes proposals to adopt and authorize an H Share Award Scheme, subject to relevant approvals and certain share issuance limits not exceeding 5% of the total shares in issue as of the date of passing the resolution. Other major items cover a Service Provider Sublimit under the H Share Award Scheme and a proposed cancellation of the Supervisory Committee, alongside amendments to the Company’s Articles of Association.</p>\n<p>Shareholders must submit completed proxy forms, together with any required authorization documents, no later than 24 hours before the scheduled start of the EGM. Attendance in person requires appropriate proof of identity. Further details and specific instructions, including procedures for voting, are outlined in the official proxy form and notice of the EGM.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09887","symbol_name":"维立志博-B","start_time":0,"source_url":"","article_id":"1137190048","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137190048","pubTimestamp":1764339792,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has released a proxy form for an Extraordinary General Meeting (EGM) scheduled for December 17, 2025, at 10:00 a.m. The EGM will take place on Floor...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09887":"维立志博-B"},"translate_title":"南京先导生物(9887)宣布于2025年12月17日召开股东特别大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1},"content_text":"Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) has released a proxy form for an Extraordinary General Meeting (EGM) scheduled for December 17, 2025, at 10:00 a.m. The EGM will take place on Floor 8, Building 03, 18E, Jialingjiang Street, Nanjing, the People’s Republic of China. Shareholders can vote in person or appoint proxies to vote on their behalf.\nThe agenda includes proposals to adopt and authorize an H Share Award Scheme, subject to relevant approvals and certain share issuance limits not exceeding 5% of the total shares in issue as of the date of passing the resolution. Other major items cover a Service Provider Sublimit under the H Share Award Scheme and a proposed cancellation of the Supervisory Committee, alongside amendments to the Company’s Articles of Association.\nShareholders must submit completed proxy forms, together with any required authorization documents, no later than 24 hours before the scheduled start of the EGM. Attendance in person requires appropriate proof of identity. Further details and specific instructions, including procedures for voting, are outlined in the official proxy form and notice of the EGM.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137190048","isCrawlerRequest":true}